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ABSTRACT. Though the rs5219 E23K variant of the KCNJ11 gene is 
commonly known to be associated with Type 2 diabetes (T2D) in 
Caucasian and Asian populations, little or none of such findings have 
been revealed in Nigeria. Hence, this study was aimed to assess the 
relationship between E23K polymorphic variant of the KCNJ11 gene 
and T2D in a Nigerian population. A case-control study involving 73 
T2D patients and 75 non-diabetic (ND) patients aged above 30 years 
was conducted. Demographic, clinical, and anthropometric data was 
collected and the fasting blood glucose (FBG), total cholesterol (TC), 
triglyceride (TG), LDL-c and HDL-c were assayed. The KCNJ11 E23K 
polymorphism was genotyped by RFLP–PCR using BanII restriction 
enzyme. There was predominance of the mutant A allele as well as the 
homozygote AA genotype (92.5%) in both T2D and ND patients than 
the wild G allele and homozygote GG genotype (7.5%). The 
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heterozygote AG genotype was completely absent in the T2D and ND 
patients. The AA genotype showed no significant risk of T2D when 
compared to the GG genotype (OR: 1.183, 95% CI: 0.345-4.059, p= 
0.790) in. Genotype frequencies did not violate the Hardy-Weinberg 
equilibrium in the study population (χ2=0.071; p=0.790). HDL-c was 
significantly higher (p=0.002) in patients with the GG genotype 
compared to the patients with the AA genotype. In conclusion, the 
KCNJ11 E23K polymorphism was not associated with T2D though there 
was predominance of the mutant A allele in the study population.                                           
Key words: Type 2 diabetes; KCNJ11 gene; E23K variant; HDL-c; 
genetic association; Nigeria 
INTRODUCTION 
Though infectious diseases and malnutrition continue to be the most predominant health related causes of 
morbidity and mortality in low-income countries (Mathers et al., 2009), chronic non-communicable diseases, 
notably type 2 diabetes (T2D) is fast becoming a major concern in these regions with its increasingly rising 
prevalence (WHO, 2016). The prevalence of diabetes in sub-Saharan Africa (SSA) alone is projected to double, 
with a rise from 15 to 28 million by the next decade (IDF, 2011).  
Though the prevalence of T2D is greatest in the Western regions particularly in Caucasians, the differences in 
the prevalence of the disease across the globe could be accounted for by demographic, ethnic, socio-economic, 
behavioral, feeding habit etc. The contribution of demographic and ethnicity on the prevalence may suggest 
certain genetic influence on the disease. With such postulation, Genome wide Association studies (GWAS) have 
screened several genes with over 60 polymorphic variants identified to have increased susceptibility and 
associated with the disease (Voight et al., 2010; Dupuis et al., 2010). 
One of such genes is the potassium inward rectifying channel subfamily J (KCNJ11). The KCNJ11 gene is a 
member of the potassium channel gene family located at 11p15 which encodes the islet ATP-sensitive 
potassium channel Kir6.2 (Haghvirdizadeh et al., 2015). The Kir6.2 protein, together with the high-affinity 
sulfonylurea receptor 1 (SUR1), forms the KATP channel which mediates insulin secretion. Mutations in the 
KCNJ11 gene can promote diabetes by altering the functioning of the KATP channel (Ashcroft, 2006). Several 
mutations of the KCNJ11 gene have been identified with about six of them receiving more attention for their 
association with diabetes (Gloyn et al., 2001).  
Among these genetic variants, a common glutamate (E) → lysine (K) change at position 23 (E23K) has 
consistently been shown to be associated with T2D, with an overall allelic odd ratio (OR) close to 1.15 (Gloyn 
et al., 2001; Gloyn et al., 2003; Nielsen et al., 2003) when diabetic individuals were compared with non-diabetic 
control subjects. More so, other studies have shown normoglycaemic subjects with the lysine genotype to 
consistently demonstrate a defect in secretion of insulin. Also, this has been confirmed In vitro, where the lysine 
risk allele seems to affect potassium channel properties (Florez et al., 2004; van Dam et al., 2005). 
The E23K variant has been reported to be associated with T2D in various ethnic populations, including 
European descent (Inoue et al., 1997), Asians (Koo et al., 2007; Zhou et al., 2009), Arab populations (Alsmadi 
et al., 2008) etc. In Africa, a few studies have been conducted on the E23K variants with inconsistent findings.  
The polymorphic lysine variant was shown to be associated with T2D in Tunisia (Lasram et al., 2014) while the 
variant was almost completely present in Ghana with over 99.9% prevalence but showed no association with 
T2D (Danquah et al., 2013). None of such findings have been revealed in Nigeria thus, this study assessed the 
KCNJ11 E23K polymorphic variant and its association with T2D in a Nigerian population.  
MATERIALS AND METHODS 
Study participants and ethical approval 
This is a continuation of an ongoing case–control study involving 73 T2D patients and 75 non-diabetic (ND) 
patients of Nigerian nationality at Enugu State University of Science and Technology Teaching Hospital 
(ESUTH) in Enugu Nigeria. Only outpatients with or without T2D above 30 years, without any critical or 
emergency health conditions or complications and not admitted at the hospital were recruited for the study.  
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Breastfeeding and/or pregnant women as well as HIV positive patients were excluded from the study. Patients 
considered as T2D patients had at least one-year history of the disease and were diagnosed according the IDF 
criteria (WHO-IDF, 2014). 
The study was conducted in accordance with the Helsinki Declaration. Before commencement of study, ethical 
clearance was obtained from the ethical committee of ESUTH Enugu, Nigeria with approval no: ESUTHP/C-
MAC/RA/034/174 and written informed consent was obtained from all willing participants before enrolment.  
Data collection  
Patients’ data including age and sex was obtained and the height, weight, and waist circumference (WC) of the 
patients were measured. The Body Mass index (BMI) was calculated from the height (m) and weight (kg) and 
expressed as kg/m2. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured using 
an automatic sphygmomanometer.  
Biochemical assays 
Fasting blood glucose (FBG) was measured from whole blood after an overnight fasting using an accucheck 
glucometer according to the glucose oxidase enzymatic method by Trinder (1969). Serum total cholesterol (TC), 
low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-
C) were assayed using kits by Randox Laboratories Ltd, United Kingdom.  
The TC was determined according to the enzymatic method of Allain and collaborators (1974), TG was 
determined by the enzymatic method of Esders and Michira (1997) and HDL-C by the precipitation method of 
Grove (1979). LDL-C was determined using the formula of Freidwald (1972): LDL-C=TC- (TG/5) - HDL-C 
Molecular genotyping of KCNJ11 E23K variant 
DNA was extracted using Thermo Scientific GeneJET Genomic DNA Purification kit (K0721) by Thermo 
Fisher Scientific.  Inc.   The E23K polymorphism of KCNJ11 gene was genotyped by the method of Jiang and 
collaborators (2014). PCR was performed with forward primer 5′-GACTCTGCAGTGAGGCCCTA-3′ and 
reverse primer 5′-ACGTTGCAGTTG CCTTTCTT-3′.  Each PCR had a final volume of 28 μL containing 8 µl 
-load 2x master mix with 
standard buffer from New England Biolab (NEB), USA.  
The amplification started with a denaturing step at 95°C for 3 min followed by 35 cycles of 95°C for 30 s, 
annealing at 60°C for 30 s, and elongation at 72°C for 30 s with a final elongation step at 72°C for 9 min. The 
PCR product after electrophoresis on 2% agarose gel was 209 bp and was digested with 0.5 ul of BanII 
restriction enzyme (5U per amplicon) by New England Biolabs, Beverly, MA using 1x NEB Smartcut buffer as 
recommended by the manufacturer (New England Biolabs, Beverly, MA) and 8 ul of nuclease free water to a 
total reaction volume of 20 ul and separated on 3% agarose gels.  
The substitution of G with A eliminated the BanII site. The expected product sizes were 150 bp and 59 bp for 
the normal homozygote GG genotype; 209 bp only for the mutant homozygote AA genotype and 209, 150 and 
59 bp for the heterozygote GA genotype.  
Statistical analysis 
Data was analyzed using Statistical Package for Social Science (SPSS) version 16. Results were expressed as 
frequencies and mean  ±  Standard error of the mean (S.E.M) and presented in tables. Parametric independent 
sample t-test was used to compare mean differences of the lipid profile indices, demographic and clinical 
characteristics for the various KCNJ11 E23K genotypes of study participants.  
Pearson chi-square (χ2) test was used to test for the Hardy-Weinberg equilibrium by comparing genotype and 
allele frequencies in the diabetic and non-diabetic subjects. Binary logistic regression was used to determine the 
odd ratio (OR) by comparing allele and genotype frequencies between diabetic and non-diabetic patients. A 
confidence interval (CI) of 95% was taken and a p-value less than 0.05 was considered statistically significant. 
RESULTS 
A total of 148 participants; 73 T2D patients and 75 ND patients were recruited for the study of which 54 were 
male and 94 were female. The proportion of male and female was not significantly different (p=0.229) between 
the T2D and ND patients. The demographic and clinical characteristics of participants are summarized in Table 
1. 
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Characteristics Diabetic Non-diabetic Minimum Maximum p-value 
Age (years) 56.87 ± 1.19 49.03 ± 1.90 30 92 0.001 
Height (m) 1.59 ± 0.01 1.61 ± 0.01 1.37 1.90 0.218 
Weight (kg) 79.16 ± 3.38 71.52 ± 1.95 35.00 190.00 0.052 
BMI (Kg/m
2
) 31.42 ± 1.38 27.81 ± 0.76 18.20 85.13 0.023 
WC (cm) 100.25 ± 1.68 89.37 ± 2.25 36.00 149.00 0.000 
SBP (mmHg) 132.95 ± 2.62 132.86 ± 3.23 100 213 0.982 
DSP (mmHg) 79.12 ± 1.38 81.76 ± 2.24 58 151 0.297 
FBG (mg/dl) 166.38 ± 11.23 65.75 ± 3.79 11.00 520.00 0.000 
Note: Results are presented as Mean ± SEM; SBP: Systolic Blood Pressure; DSP: Diastolic Blood Pressure; FBG: Fasting Blood Glucose; 
BMI: Body Mass Index; WC: Waist Circumference 
 
The KCNJ11 E23K (G/A) gene fragment was successfully amplified for all study participants with a molecular 
size of 209 bp (Figure 1).  
 
Figure 1. RFLP-PCR of KCNJ11 E23K Polymorphism. MWM: molecular weight marker. UD indicates undigested amplified sample. D01 
to D06 are digested samples and were all the mutant homozygote AA genotype. 
After restriction enzyme digestion, the product sizes were 150 bp and 59 bp for the normal homozygous GG 
genotype and 209 bp only for the mutant homozygous AA genotype (Figure 2).   
 
Figure 2. Digested samples of the KCNJ11 gene. MWM: Molecular Weight Marker. NC indicates the negative control. D08 sample 
indicates the homozygote GG genotype and D09 is the mutant homozygote AA genotype. 
 
Table 1: Demographic and clinical characteristics of participants 
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The heterozygous GA genotype was absent and the 59 bp was not visualized. There was predominance of the A 
allele as well as the homozygous AA genotype (92.5%) in both T2D and ND patients than the G allele and 
homozygote GG genotype (7.5%). The heterozygous GA genotype was completely absent in the T2D and ND 
patients. Because of the absence of the heterozygote AG genotype, the dominant and recessive models could not 
be tested for risk of T2D. For the codominant model (GG vs AA), there was no significant risk (OR: 1.183, 95% 
CI: 0.345-4.059) of the AA genotype with T2D compared to the GG genotype as there was no significant 
difference (p =0.790) of the polymorphic variant (AA genotype) between T2D patients (45.9%) and ND patients 
(46.6%). Genotype frequencies did not violate the Hardy-Weinberg equilibrium in the study population 
(χ2=0.071; p=0.790). Results are summarized in Table 2. 
 
KCNJ11 G/A 
variant 
T2D (%) ND (%) OD (95% CI) p-value χ2 p-value 
Allele       
G 10 (3.4) 12 (4.1) -------    
A 136 (45.9) 138 (46.6) 1.183 (0.494-2.828) 0.706   
Total 146 (49.3) 150 (50.7)     
Genotype       
GG 5 (3.4) 6 (4.1) ------    
AG 0 (0.0) 0 (0.0) ------    
AA 68 (45.9) 69 (46.6) 1.183 (0.345-4.059) 
1.421 (0.394-5.119 
0.790 
0.591 
0.071 0.790 
Total 73 (49.3) 75 (50.7)     
Note: OR: Odd Ratio,  Indicates age adjusted OR, CI: Confidence Interval, χ2: Chi-square 
Comparison of study parameters of participants with the various genotypes showed the ages of patients with the 
GG genotype to be significantly higher (p=0.004) than those of the AA genotype. Also, the HDL was 
significantly higher (p =0.002) in patients with the GG genotype compared to the patients with the AA 
genotype.  However, the anthropometric measures (WC and BMI), FBG and most of the lipids parameters (TC, 
TG and LDL-c) did not show any significant differences (p < 0.05) between the GG and AA genotypes (Table 
3). 
 
 GG (E) AA (K) p-value 
 
 
Age (yr) 
 
 
64.45 ± 5.37 
 
 
51.92 ± 1.16 
 
 
0.004 
 
 
WC (cm) 
 
 
94.27 ± 2.73 
 
 
94.94 ± 1.58 
 
 
0.902 
 
 
BMI (Kg/m
2
) 
 
 
32.57 ± 5.99 
 
 
29.36 ± 0.733 
 
 
0.299 
 
 
FBG (mg/dl) 
 
 
112.67 ± 20.88 
 
 
115.92 ± 7.61 
 
 
0.914 
 
 
TC (mg/dl) 
 
 
194.02 ± 14.52 
 
 
226.22 ± 16.78 
 
 
0.587 
 
 
TG (mg/dl) 
 
 
169.42 ± 63.54 
 
 
196.13 ± 8.74 
 
 
0.451 
 
 
LDL-c (mg/dl) 
 
 
103.37 ± 22.29 
 
 
147.15 ± 16.99 
 
 
0.467 
 
 
HDL-c (mg/dl)   
 
 
81.16 ± 20.30 
 
 
45.80 ± 2.80 
 
 
0.002 
 
Note: Results are expressed as mean  ±  S.E.M; S.E.M: Standard error of the mean 
 
Table 2: Association between the KCNJ11 E23K (G/A) polymorphism and T2D 
Table 3: Relationship between KCNJ11 (G/A) polymorphism and some study 
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DISCUSSION 
T2D is a complex metabolic disease caused by multiple environmental and genetic factors whereby the level of 
heritability from twin and family studies is estimated at 22% - 73% (Kaprio, et al., 1992; Poulsen et al., 1999). 
After the identification of over 40 T2D-associated genetic loci primarily from studies involving mainly 
individuals of European ancestry, other candidate-gene association studies have discovered association between 
T2D and a few missense variants including KCNJ11 which is an antidiabetic drug target site (Gloyn et al., 
2001). It was proposed that this missense mutation may alter the charge of the ATP-binding region and decrease 
channel sensitivity to ATP. Among the variants of KCNJ11, the rs5219 E23K polymorphism due to a change 
from G to A has been shown to be associated with T2D in diverse ethnic populations in several studies 
(Abdelhamid et al., 2014). Several meta-analysis and association studies have showed a strong association 
between the E23K polymorphism and susceptibility to T2D mostly in Caucasians and in some Asian 
populations (Gonen et al., 2012; He et al., 2008; Chistiakov et al., 2003). However, some other association 
studies did not show any relationship between this polymorphism and susceptibility to T2D (Keshavarz et al., 
2014; Gamboa-Mel´endez et al., 2012; Souza et al., 2016). More so, some populations notably from East Asia 
showed the mutant A allele to be more frequent in the non-diabetic controls than the diabetic patients (Qiu et al., 
2014). In Africa, just a few studies have assessed this polymorphism notably in Tunisia and Ghana. In the 
Tunisia study, this polymorphism was shown to be T2D-associated with a frequency of the A allele above 35% 
in both the diabetic patients and control subjects (Lasram et al., 2014). On the other hand, this polymorphic 
variant did not show any association with T2D in a Ghanaian population as there was over 99.9% predominance 
of the mutant A allele as well as the AA (K) genotype (Danquah et al., 2013). In this present study, there was a 
92.5% predominance of the mutant A allele as well as the AA genotype in both the T2D and the ND patients 
and thus, the E23K polymorphism was not associated with T2D as the difference between this polymorphic 
variant in T2D patients (45.9%) and the ND patients (46.9%) was not significant (OR: 1.183, 95% CI: 0.345-
4.059, p=0.790). The genotype frequencies did not violate the Hardy-Weinberg equilibrium in this population 
(χ2=0.071; p=0.790). Since the mutant AA genotype frequency was very high in a Nigerian population in this 
study and in a Ghana population in a previous study; both countries of the sub-Saharan region, it is suggested 
that the A allele may seem to be the wild allele in this region of Africa. 
Owing to the fact that insulin plays multiple roles in the body including carbohydrate and lipid metabolism, the 
relationship between the KCNJ11 E23K polymorphism with blood sugar, obesity, cholesterol, triglyceride, and 
lipoproteins was assessed. Findings from this study did not show any significant differences in the 
anthropometric or obesity parameters (BMI, WC), FBG and some serum lipids (TC, TG and LDL-c) between 
the GG and AA genotypes of patients. This confirms the findings of a previous study which also showed no 
association of this polymorphism with anthropometric parameter, obesity, and body fat (Lasram et al., 2014). 
However, HDL level was significantly lower (p < 0.002) in patients with the AA genotype compared to the GG 
genotype. This may suggest that the GG genotype can improve the HDL level in patients with T2D which has 
an essential role to remove free cholesterol in blood thus having a protective effect against T2D as high HDL-c 
level is known to reduce susceptibility to T2D.  
CONCLUSION 
In conclusion, this study showed no associated risk of the KCNJ11 E23K polymorphism with T2D though there 
was predominance of the mutant A allele and AA genotype in both T2D patients and the non-diabetic control 
patients. The GG genotype was associated with high level of HDL-c suggesting a possible protective effect of 
reducing susceptibility to T2D.  
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